BCRX  Biocryst Pharmaceuticals Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Market Cap.

536.8M

Vuru Grade

23.50/100

Current Price

$9.04
+0.70 (+8.39%)

Stability Price

$1.38
Overvalued by 84.75%

Company Metrics

  • 0 P/E
  • 28.58 P/S
  • 197.59 P/B
  • -0.545 EPS
  • -156.52% Cash ROIC
  • 1.59 Cash Ratio
  • 0 / 0% Dividend
  • 1.09M Avg. Vol.
  • 45.14M Shares
  • 536.8M Market Cap.

Company Description

BioCryst Pharmaceuticals, Inc. designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer modeling to develop new therapeutic candidates. The com...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

There is no news available at this time.